Institution size | Small 1–500 beds | Medium 501–1000 beds | Large above 1000 beds | ||||||||
n | Mean | ±SD | n | Mean | ±SD | n | Mean | ±SD | |||
Workload increase* (hours/day/pharmacy) | Pharmacist | Initial | 19 | 0.86 | 1.25 | 11 | 0.96 | 0.71 | 13 | 0.96 | 0.78 |
Future | 0.74 | 1.78 | 1.30 | 1.23 | 1.58 | 1.73 | |||||
Technician | Initial | 2.03 | 1.54 | 1.54 | 0.56 | 3.19 | 1.32 | ||||
Future | 3.05 | 3.47 | 2.75 | 1.32 | 6.38 | 4.84 | |||||
Non-human investments† (EUR/pharmacy) | IT | Initial | 18 | 855 | 648 | 10 | 1292 | 628 | 13 | 2486 | 2038 |
Future | 5 | 853 | 345 | 5 | 1280 | 362 | 3 | 803 | 609 | ||
Infrastructure | Initial | 2 | 226 | 106 | 3 | 224 | 328 | 7 | 2810 | 4930 | |
Future | 3 | 873 | 740 | 3 | 497 | 613 | 0 | – | – |
*Initial change until implementation as of February 2019, and estimated future change during the stabilisation period until all prescription-only medicine packages are serialised.
†Descriptive data are presented for institutions providing data on self-financed investments necessary to meet FMD requirements. Currency conversion rate is €1=3HUF332, as of September 2019, the time of survey.
FMD, Falsified Medicines Directive.